Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a government funding/operating-status notice and bumped version to v3.2.0, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-07T23:09:44.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0, updating the page version identifier.
    Difference
    0.1%
    Check dated 2025-09-30T02:39:57.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other substantive changes to pricing, timeslots, or named entities.
    Difference
    0.1%
    Check dated 2025-09-15T19:23:35.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-08T15:00:59.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms related to acute myeloid leukemia and various chemical compounds. Notably, previous references to acute graft versus host disease and other leukemia types have been removed.
    Difference
    2%
    Check dated 2025-09-01T09:34:28.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.5%
    Check dated 2025-08-25T05:36:39.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.